Efficacy Determinants of Subcutaneous Microdose Glucagon during Closed-Loop Control
Open Access
- 1 November 2010
- journal article
- clinical trial
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 4 (6) , 1288-1304
Abstract
Background: During a previous clinical trial of a closed-loop blood glucose (BG) control system that administered insulin and microdose glucagon subcutaneously, glucagon was not uniformly effective in preventing hypoglycemia (BG 60%. After the algorithm PK parameters were globally adjusted, insulin dosing was more conservative and microdose glucagon administration was very effective in reducing hypoglycemia while maintaining normal plasma glucagon levels. Improvements in the accuracy of the controller's online estimate of plasma insulin levels could be achieved if ultrarapid-acting insulin formulations could be developed with faster absorption and less intra- and intersubject variability than the current insulin analogs available today.Keywords
This publication has 26 references indexed in Scilit:
- A Bihormonal Closed-Loop Artificial Pancreas for Type 1 DiabetesScience Translational Medicine, 2010
- Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 DiabetesDiabetes Care, 2010
- Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetesJournal of Endocrinology, 2008
- Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial PancreasDiabetes Care, 2008
- Feasibility of Automating Insulin Delivery for the Treatment of Type 1 DiabetesDiabetes, 2006
- Insulin AnaloguesNew England Journal of Medicine, 2005
- Subcutaneous Glucose Concentration in Humans: Real estimation and continuous monitoringDiabetes Care, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- WEARABLE ARTIFICIAL ENDOCRINE PANCREAS WITH NEEDLE-TYPE GLUCOSE SENSORThe Lancet, 1982
- Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell DefectScience, 1973